U.S. Markets close in 1 hr 1 min

Monteverde & Associates PC Files Class Action Lawsuit on Behalf of Stockholders of Osiris Therapeutics, Inc. in the U.S. District Court for the Southern District of New York

NEW YORK, NY / ACCESSWIRE / April 9, 2019 / Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Southern District of New York, Case No. 1:19-cv-02657-VSB, on behalf of the public common stockholders Osiris Therapeutics, Inc. (''Osiris'' or the ''Company'') (NASDAQ: OSIR) who held shares of Osiris common stock on the record date March 19, 2019 (the ''Class Period''), and have been harmed by Osiris and its board of directors' (the ''Board'') alleged violations of Sections 14(d)(4), 14(e), and 20(a) of the Securities Exchange Act of 1934 (the ''Exchange Act'') in connection with the with the proposed tender offer by Smith & Nephew plc to acquire all of the issued and outstanding shares of Osiris (the ''Proposed Transaction'').

Under the terms of the Proposed Transaction, Osiris stockholders will only receive $19.00 in cash for each share of Osiris common stock they own (the ''Offer Price''). The complaint alleges that the Offer Price is inadequate and that the Schedule 14D-9 Solicitation/Recommendation Statement regarding the Proposed Transaction (the ''Recommendation Statement'') provides stockholders with materially incomplete and misleading information about the Proposed Transaction, in violation of Sections 14(d)(4), 14(e), and 20(a) of the Exchange Act. In particular, the Recommendation Statement alleges materially incomplete and misleading information concerning: (i) financial projections for Osiris; and (ii) the valuation analyses performed by Osiris' financial advisor, Cantor Fitzgerald & Co., in support of its fairness opinion. The Tender Offer is scheduled to expire at 12:01 a.m. Eastern Time, on April 17, 2019.

If you wish to serve as lead plaintiff, you must move the Court no later than June 10, 2019. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

Click here for more information: https://www.monteverdelaw.com/case/osiris-therapeutics-inc. It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a national class action securities and consumer litigation law firm committed that has recovered millions ofdollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates PC lawyers have significant experience litigating mergers & acquisitions and securities class actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017, and 2018, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017 and 2018 Top Rated Lawyer.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave, Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC



View source version on accesswire.com:
https://www.accesswire.com/541529/Monteverde-Associates-PC-Files-Class-Action-Lawsuit-on-Behalf-of-Stockholders-of-Osiris-Therapeutics-Inc-in-the-US-District-Court-for-the-Southern-District-of-New-York